The results demonstrated that, compared to the control group, the knockdown of STMN1 resulted in a significant reduction in both ovarian cancer cell proliferation and wound healing rate (Fig. 1J-L, Figure S5), further substantiating the critical role of STMN1 in ovarian cancer progression. This evidence concerns the gene STMN1 and ovarian carcinoma.